{"id":"W2565340265","doi":"10.1016/j.trci.2016.12.003","title":"Active Aβ immunotherapy CAD106 in Alzheimer's disease: A phase 2b study","year":2016,"lang":"en","type":"article","venue":"Alzheimer s & Dementia Translational Research & Clinical Interventions","topic":"Alzheimer's disease research and treatments","field":"Medicine","cited_by":136,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto","funders":"Novartis Pharma; Strong","keywords":"Medicine; Tolerability; Placebo; Internal medicine; Adverse effect; Adjuvant; Gastroenterology; Serology; Immunology; Antibody; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow","insufficient_payload"],"consensus_categories":["insufficient_payload"],"category_scores_codex":[0.003567836,0.0004386906,0.0007472385,0.0008803672,0.0004405546,0.000102073,0.0005422529,0.0001854067,0.005985262],"category_scores_gemma":[0.0005240507,0.0003238368,0.001346905,0.001008328,0.000896023,0.0006580721,0.0001683872,0.0009759691,0.000832468],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00007153579,"about_ca_system_score_gemma":0.001124727,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000273923,"about_ca_topic_score_gemma":0.0004874448,"domain_scores_codex":[0.9912164,0.002021299,0.001907084,0.00123567,0.002373845,0.001245674],"domain_scores_gemma":[0.9943804,0.0021233,0.0001911536,0.0009983957,0.000933115,0.001373681],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"observational","study_design_gemma":"observational","study_design_scores_codex":[0.01329003,0.0575179,0.4183871,0.00003019991,0.1864849,0.0008941126,0.0002493439,0.000002188923,0.0001264685,0.001430105,0.002088703,0.319499],"study_design_scores_gemma":[0.03882009,0.005372582,0.931226,0.0009078081,0.0132603,0.00001005684,0.0002984869,0.0001673945,0.000247027,0.005096342,0.00407872,0.0005151938],"study_design_candidate":"observational","study_design_consensus":"observational","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.6807094,0.2801074,0.001325495,0.02118487,0.0005446995,0.01195467,0.001549043,0.0002670848,0.002357367],"genre_scores_gemma":[0.996145,0.001304783,0.0003563376,0.0001089785,0.0002521553,0.00134542,0.0003232604,0.00008779013,0.00007633746],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.5128389,"threshold_uncertainty_score":0.9999455,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.3190082853627753,"score_gpt":0.5553090210123203,"score_spread":0.236300735649545,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}